MediPharm Labs Corp. (OTCMKTS:MEDIF) Sees Significant Decline in Short Interest

MediPharm Labs Corp. (OTCMKTS:MEDIF) was the recipient of a significant decrease in short interest in September. As of September 15th, there was short interest totaling 59,000 shares, a decrease of 29.5% from the August 31st total of 83,700 shares. Based on an average trading volume of 139,200 shares, the days-to-cover ratio is presently 0.4 days. Based on an average trading volume of 139,200 shares, the days-to-cover ratio is presently 0.4 days.

MediPharm Labs Stock Performance

Shares of OTCMKTS:MEDIF opened at $0.06 on Monday. The company’s fifty day moving average is $0.05 and its 200-day moving average is $0.06. MediPharm Labs has a 52 week low of $0.04 and a 52 week high of $0.09.

About MediPharm Labs

MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products.